Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / Common Stock, par value $0.000001 per share
-
Shares outstanding
-
139M
-
Number of holders
-
26
-
Total 13F shares, excl. options
-
90.1M
-
Shares change
-
-307K
-
Total reported value, excl. options
-
$56.7M
-
Value change
-
-$436K
-
Number of buys
-
8
-
Number of sells
-
-20
-
Price
-
$0.63
Significant Holders of Xtant Medical Holdings, Inc. - Common Stock, par value $0.000001 per share (XTNT) as of Q2 2024
35 filings reported holding XTNT - Xtant Medical Holdings, Inc. - Common Stock, par value $0.000001 per share as of Q2 2024.
Xtant Medical Holdings, Inc. - Common Stock, par value $0.000001 per share (XTNT) has 26 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 90.1M shares
of 139M outstanding shares and own 64.66% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (73.1M shares), Altium Capital Management LP (7.42M shares), Nantahala Capital Management, LLC (3.58M shares), VANGUARD GROUP INC (2.15M shares), Juniper Investment Company, LLC (1.32M shares), RENAISSANCE TECHNOLOGIES LLC (704K shares), GEODE CAPITAL MANAGEMENT, LLC (303K shares), BRIDGEWAY CAPITAL MANAGEMENT, LLC (294K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (239K shares), and Crescent Grove Advisors, LLC (212K shares).
This table shows the top 26 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.